BUYRAK KISTALARINI DIAGNOSTIKA QILISH VA DAVOLASHDA QAYSI METODLARNING BIR BIRIDAN AFZALGINI BAHOLASH: ADABIYOTLAR SHARHI.
Ключевые слова:
buyrak kistasi, Bosniak klassifikatsiyasi, kistoz buyrak hosilasi, skleroterapiya, laparoskopik dekortikatsiyaАннотация
Dolzarbligi
Buyrak kistalari klinik amaliyotda uchraydigan eng keng tarqalgan kistoz buyrak hosilalaridan biri bo‘lib, ko‘pincha kompyuter tomografiyasi (KT) yoki magnit-rezonans tomografiya (MRT) kabi tasvirlash tekshiruvlari vaqtida tasodifan aniqlanadi. Ularning aksariyati oddiy, xavfsiz va klinik jihatdan ahamiyatsiz bo‘lsa-da, murakkab kistoz buyrak hosilalarining ma’lum bir qismi malignizatsiya (saraton) xavfiga ega. Shu sababli diagnostika va davolash taktikasi radiologik xavf stratifikatsiyasining aniqligiga bog‘liq.
Maqsad
Oddiy va murakkab buyrak kistalarining diagnostikasi hamda davolashiga oid zamonaviy ilmiy dalillar va xalqaro tavsiyalarni (Yevropa Urologlar Assotsiatsiyasi [EAU] hamda Amerika Urologlar Assotsiatsiyasi [AUA]) umumlashtirish, shuningdek, tasvirlash usullarining diagnostik samaradorligi, minimal invaziv muolajalar va jarrohlik natijalari hamda yangi diagnostik texnologiyalarning o‘rnini baholash.
Materiallar va usullar
Ushbu ish strukturallashgan narrativ sharh hisoblanadi. Adabiyotlar PubMed/MEDLINE, Scopus bazasiga kiritilgan jurnallar va professional jamiyatlar tavsiyalaridan (EAU Renal Cell Carcinoma Guidelines 2024–2025, AUA Renal Mass and Localized Renal Cancer Guideline) maqsadli qidiruv orqali tanlab olindi. Bunda 2015-yildan keyin chop etilgan maqolalarga ahamiyat berildi, shuningdek Bosniak klassifikatsiyasining asoslarini shakllantirgan fundamental tadqiqotlar ham ko‘rib chiqildi. Tadqiqot narrativ sintez shaklida bo‘lgani sababli yangi meta-tahlil yoki umumlashtirilgan statistik hisob-kitoblar amalga oshirilmadi; keltirilgan barcha sonli ko‘rsatkichlar asl manbalardan olingan.
Natijalar
2019-yilda MRTni rasman o‘z ichiga olgan holda yangilangan Bosniak klassifikatsiyasi murakkab buyrak kistalarini xavf bo‘yicha baholashning asosiy mezoni bo‘lib qolmoqda. Malignizatsiya xavfi Bosniak I va II toifalarda deyarli mavjud emas, biroq IIF, III va IV kategoriyalarda sezilarli darajada ortadi.
Kontrast kuchaytirilgan ultratovush tekshiruvi (CEUS) murakkab holatlarni aniqlashtirishda muhim diagnostik vosita sifatida namoyon bo‘lmoqda. Bir qator istiqbolli tadqiqotlarda malign jarayonlarni aniqlash sezgirligi 96–100% oralig‘ida qayd etilgan bo‘lib, ayrim klinik vaziyatlarda CEUS KT va MRT natijalarini to‘ldirishi yoki ulardan ustun bo‘lishi mumkin.
Simptomatik oddiy kistalarda perkutan aspiratsiya va skleroterapiya usullarining samaradorligi qo‘llanilgan texnikaga (bir martalik yoki ko‘p martalik muolaja, etanol konsentratsiyasi va boshqalar) qarab odatda 70–95% ni tashkil etadi. Laparoskopik dekortikatsiya o‘tkazilgan 696 nafar bemorni o‘z ichiga olgan umumlashtirilgan tahlilda radiologik muvaffaqiyat darajasi 96%, simptomatik yaxshilanish darajasi 95% bo‘lgan, intraoperatsion va operatsiyadan keyingi asoratlarning umumiy ko‘rsatkichi esa 2% dan kamni tashkil etgan.
Bosniak III–IV kategoriyadagi kistalarda zamonaviy dalillar mos tanlangan bemorlarda faol kuzatuv (active surveillance) usulini birlamchi jarrohlik amaliyotiga muqobil variant sifatida qo‘llash mumkinligini ko‘rsatmoqda.
Xulosa
Buyrak kistalarini boshqarish Bosniak kategoriyasi, simptomlarning og‘irligi va bemorning individual xavf omillarini hisobga olgan holda individuallashtirilishi lozim. Oddiy kistalar (Bosniak I–II) odatda davolashni talab qilmaydi va faqat simptomlar mavjud bo‘lganda aralashuv ko‘rsatiladi. Simptomatik oddiy kistalarda perkutan skleroterapiya yoki laparoskopik dekortikatsiya yuqori samaradorlikka ega. Murakkab kistalarda (Bosniak IIF–IV) esa faol kuzatuv va intervension davolash o‘rtasidagi tanlov bemor bilan birgalikda qabul qilinishi kerak. Bu jarayonda CEUS, radiomika va boshqa zamonaviy tasviriy texnologiyalar tobora muhim ahamiyat kasb etmoqda.
##plugins.themes.default.displayStats.downloads##
Библиографические ссылки
1. Comparison of Bosniak classification version 2005 vs. 2019 for class distribution, diagnostic performance, and interreader agreement using CT and MRI. AJR Am J Roentgenol. doi:10.2214/AJR.21.25796.
2. European Association of Urology. EAU Guidelines on Renal Cell Carcinoma. Presented at EAU Annual Congress, Paris; 2024.
3. Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I. J Urol. 2021;206(2):199–208.
4. Colombo I, et al. Active surveillance versus initial surgery in the long-term management of Bosniak IIF–IV cystic renal masses. Sci Rep. 2022. doi:10.1038/s41598-022-14056-6.
5. Nolazco JI, Tang Y, Chang SL. Active surveillance for complex renal cysts: is it time for III-F and IV-F? AME Med J. 2022;7:31.
6. Kim SH, et al. CT-guided sclerotherapy for simple renal cysts: value of ethanol concentration monitoring. Korean J Radiol. 2014;15(1):80–88. doi:10.3348/kjr.2014.15.1.80.
7. Percutaneous ethanol sclerotherapy of renal cysts: treatment outcomes and literature review. Radiol Bras.
8. Percutaneous treatment of simple renal cysts with 24-h-interval ethanol sclerotherapy. Int Braz J Urol / equivalent. PMC10013184.
9. Ethanol sclerotherapy for symptomatic simple renal cysts. Br J Urol / equivalent. PubMed PMID 7550273.
10. Efficacy and safety of ultrasound-guided percutaneous aspiration-sclerotherapy with anhydrous ethanol for adult simple renal cyst: a multicenter, prospective, randomized controlled trial. PMC12290762.
11. Efficacy of single-session 99.5% ethanol sclerotherapy for incidentally found simple renal cysts. PMC9771283.
12. Laparoscopic decortication of simple renal cysts: a systematic review and meta-analysis to determine efficacy and safety of this procedure. PubMed PMID 30889610.
13. Management of Renal Cysts. PMC4376217.
14. Neves JB, et al. Role of contrast-enhanced ultrasound in assessing indeterminate renal lesions and Bosniak ≥2F complex renal cysts found incidentally on CT or MRI. Br J Radiol. 2021. PMC8553198.
15. Prospective comparison of contrast-enhanced ultrasound and magnetic resonance imaging to computed tomography for the evaluation of complex cystic renal lesions. Urology / equivalent, ScienceDirect.
16. Renal complex cystic masses: usefulness of contrast-enhanced ultrasound (CEUS) in their assessment and its agreement with computed tomography. PubMed PMID 27787749.
17. Evaluation of cystic and solid renal lesions with contrast-enhanced ultrasound: a retrospective study. PMC8315990.
18. Contrast-enhanced ultrasound in renal cystic lesions: an update. J Med Ultrason. 2024. doi:10.1007/s10396-024-01489-x.
19. An ultrasound renal cyst prevalence survey: specificity data for inherited renal cystic diseases. PubMed PMID 8250026.
20. Prevalence and clinical characteristics of simple renal cyst. PubMed PMID 18063502.
21. Radiomics for differential diagnosis of Bosniak II–IV renal masses via CT imaging. BMC Cancer. 2024. doi:10.1186/s12885-024-13283-6.
22. Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses. Nat Commun. 2025. doi:10.1038/s41467-025-56784-z.
